Mimedx (MDXG) Depreciation & Amortization (CF) (2011 - 2026)
Mimedx recorded quarterly Depreciation & Amortization (CF) of $528000.0 in Q1 2026, down 7.69% quarter-over-quarter from $572000.0 in Q4 2025, and down 5.38% year-over-year from $558000.0 in Q1 2025.
Mimedx's Depreciation & Amortization (CF) history runs 16 years deep, the most recent figure standing at $528000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 5.38% year-over-year to $528000.0; the TTM figure through Mar 2026 stood at $2.2 million (down 1.33% YoY), while the FY2025 annual figure was $14.9 million, up 146.33% from the prior year.
- Depreciation & Amortization (CF) came in at $528000.0 for Q1 2026 at Mimedx, down from $572000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $860000.0 in Q1 2022 to a low of $528000.0 in Q1 2026.
- A 5-year average of $650470.6 and a median of $580000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) sank 34.3% in 2022 and rose 1.42% in 2025, its largest moves.
- Mimedx's Depreciation & Amortization (CF) stood at $796000.0 in 2022, then declined by 23.24% to $611000.0 in 2023, then decreased by 7.69% to $564000.0 in 2024, then grew by 1.42% to $572000.0 in 2025, then decreased by 7.69% to $528000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $528000.0, $572000.0, and $572000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 528,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 528,000.00 |
| Mar 31, 2026 | 528,000.00 |
| Dec 31, 2025 | 572,000.00 |
| Dec 31, 2025 | 572,000.00 |
| Sep 30, 2025 | 572,000.00 |
| Sep 30, 2025 | 572,000.00 |
| Jun 30, 2025 | 558,000.00 |
| Jun 30, 2025 | 558,000.00 |
| Mar 31, 2025 | 558,000.00 |
| Mar 31, 2025 | 558,000.00 |
| Dec 31, 2024 | 564,000.00 |
| Dec 31, 2024 | 564,000.00 |
| Sep 30, 2024 | 580,000.00 |
| Sep 30, 2024 | 580,000.00 |
| Jun 30, 2024 | 558,000.00 |
| Jun 30, 2024 | 558,000.00 |
| Mar 31, 2024 | 558,000.00 |
| Mar 31, 2024 | 558,000.00 |
| Dec 31, 2023 | 611,000.00 |
| Dec 31, 2023 | 611,000.00 |
| Sep 30, 2023 | 653,000.00 |
| Sep 30, 2023 | 653,000.00 |
| Jun 30, 2023 | 687,000.00 |
| Jun 30, 2023 | 687,000.00 |
| Mar 31, 2023 | 714,000.00 |
| Mar 31, 2023 | 714,000.00 |
| Dec 31, 2022 | 796,000.00 |
| Dec 31, 2022 | 796,000.00 |
| Sep 30, 2022 | 831,000.00 |
| Sep 30, 2022 | 831,000.00 |
| Jun 30, 2022 | 858,000.00 |
| Jun 30, 2022 | 858,000.00 |
| Mar 31, 2022 | 860,000.00 |
| Mar 31, 2022 | 860,000.00 |
| Dec 31, 2021 | 973,000.00 |
| Dec 31, 2021 | 973,000.00 |
| Sep 30, 2021 | 923,000.00 |
| Sep 30, 2021 | 923,000.00 |
| Jun 30, 2021 | 1.31 Mn |
| Jun 30, 2021 | 1.31 Mn |
| Mar 31, 2021 | 1.16 Mn |
| Mar 31, 2021 | 1.16 Mn |
| Dec 31, 2020 | 1.29 Mn |
| Dec 31, 2020 | 1.29 Mn |
| Sep 30, 2020 | 1.57 Mn |
| Sep 30, 2020 | 1.57 Mn |
| Jun 30, 2020 | 1.42 Mn |
| Jun 30, 2020 | 1.42 Mn |
| Mar 31, 2020 | 1.51 Mn |
| Mar 31, 2020 | 1.51 Mn |
| Dec 31, 2019 | 1.57 Mn |
| Dec 31, 2019 | 1.57 Mn |
| Sep 30, 2019 | 1.64 Mn |
| Sep 30, 2019 | 1.64 Mn |
| Jun 30, 2019 | 1.60 Mn |
| Jun 30, 2019 | 1.60 Mn |
| Mar 31, 2019 | 1.70 Mn |
| Mar 31, 2019 | 1.70 Mn |
| Dec 31, 2018 | 1.95 Mn |
| Dec 31, 2018 | 1.95 Mn |
| Sep 30, 2018 | 1.40 Mn |
| Sep 30, 2018 | 1.40 Mn |
| Jun 30, 2018 | 1.30 Mn |
| Jun 30, 2018 | 1.30 Mn |
| Mar 31, 2018 | 1.22 Mn |
| Mar 31, 2018 | 1.22 Mn |
| Dec 31, 2017 | 1.01 Mn |
| Dec 31, 2017 | 1.01 Mn |
| Sep 30, 2017 | 1.01 Mn |
| Sep 30, 2017 | 1.01 Mn |
| Jun 30, 2017 | 1.12 Mn |
| Jun 30, 2017 | 1.12 Mn |
| Mar 31, 2017 | 946,000.00 |
| Mar 31, 2017 | 946,000.00 |
| Dec 31, 2016 | 939,000.00 |
| Dec 31, 2016 | 939,000.00 |
| Sep 30, 2016 | 838,000.00 |
| Sep 30, 2016 | 838,000.00 |
| Jun 30, 2016 | 821,000.00 |
| Jun 30, 2016 | 821,000.00 |
| Mar 31, 2016 | 734,000.00 |
| Mar 31, 2016 | 734,000.00 |
| Dec 31, 2015 | 552,000.00 |
| Dec 31, 2015 | 552,000.00 |
| Sep 30, 2015 | 470,000.00 |
| Sep 30, 2015 | 470,000.00 |
| Jun 30, 2015 | 422,000.00 |
| Jun 30, 2015 | 422,000.00 |
| Mar 31, 2015 | 354,000.00 |
| Mar 31, 2015 | 354,000.00 |
| Dec 31, 2014 | 333,000.00 |
| Dec 31, 2014 | 333,000.00 |
| Sep 30, 2014 | 313,000.00 |
| Sep 30, 2014 | 313,000.00 |
| Jun 30, 2014 | 288,000.00 |
| Jun 30, 2014 | 288,000.00 |
| Mar 31, 2014 | 263,000.00 |
| Mar 31, 2014 | 263,000.00 |
| Dec 31, 2013 | 214,476.00 |
| Dec 31, 2013 | 214,476.00 |
| Sep 30, 2013 | 185,000.00 |
| Sep 30, 2013 | 185,000.00 |
| Jun 30, 2013 | 139,000.00 |
| Jun 30, 2013 | 139,000.00 |
| Mar 31, 2013 | 98,751.00 |
| Mar 31, 2013 | 98,751.00 |
| Dec 31, 2012 | 110,575.00 |
| Dec 31, 2012 | 110,575.00 |
| Sep 30, 2012 | 122,934.00 |
| Sep 30, 2012 | 122,934.00 |
| Jun 30, 2012 | 121,103.00 |
| Jun 30, 2012 | 121,103.00 |
| Mar 31, 2012 | 110,388.00 |
| Mar 31, 2012 | 110,388.00 |
| Dec 31, 2011 | 115,651.00 |
| Dec 31, 2011 | 115,651.00 |
| Sep 30, 2011 | 98,989.00 |
| Sep 30, 2011 | 98,989.00 |
| Jun 30, 2011 | 115,682.00 |
| Jun 30, 2011 | 115,682.00 |
| Mar 31, 2011 | 116,180.00 |
| Mar 31, 2011 | 116,180.00 |